Technology Transfer

Dec 01, 2017
BioPharm International
A technology roadmap aims to drive and consolidate improvements in a process that has remained unchanged for more than 70 years.
Nov 28, 2017
By BioPharm International Editors
The acquisition gives GE Healthcare access to a nanofiber-based platform purification technology that can offer improvements in biopharmaceutical productivity.
Nov 15, 2017
BioPharm International
This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.
Oct 24, 2017
By BioPharm International Editors
How soon could the pharmaceutical industry see a widespread adoption of emerging technologies that are poised to shape its future?
Oct 23, 2017
By BioPharm International Editors
The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
May 15, 2017
BioPharm International
Good project management, budgeting, planning, and clear documentation are the only ways to prevent overruns and project failure.
Mar 01, 2017
BioPharm International
Communication and taking the time to develop the process are key to successful transfer and scale up of biologics
Oct 15, 2016
BioPharm International
Classical production in cell-based systems such as mammalian and bacterial cells requires cell line development and lengthy process development to support scale-up. With plant technology, generic plant bioreactors can be grown rapidly and then transfected with a transient vector based system to produce proteins in days. Large-scale commercial facilities are now available in the US, enabling clinical or commercial production of significant quantities of therapeutic materials within a year.
Apr 01, 2016
BioPharm International
Careful planning, adequate staffing levels, and experienced project managers can help avoid pitfalls of transferring processes from one facility to another.
Nov 05, 2015
By BioPharm International Editors
South Africa’s Biovac Institute, which develops and produces vaccines for the country, launched a public-private partnership with Pfizer to enable local manufacturing of Prevenar 13, a vaccine against pneumonia-causing bacteria.
native1_300x100
lorem ipsum